Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism : a Canadian analysis using the Ontario Ministry of Health perspective

Autoria(s): McDonald, Heather; Diamantopoulos, Alex; Wells, Philip; Lees, Michael; Folkerts, Kerstin; Forster, Fiona; Ananthapavan, Jaithri
Data(s)

01/10/2012
Identificador

http://hdl.handle.net/10536/DRO/DU:30063116
Idioma(s)

eng
Publicador

Informa Healthcare
Relação

http://dro.deakin.edu.au/eserv/DU:30063116/ananthapavan-costeffectivenessrivaroxaban-2012.pdf

http://doi.org/10.3111/13696998.2012.684116
Direitos

2012, Informa Healthcare
Palavras-Chave #cost-effectiveness #health economics #orthopaedic surgery #rivaroxaban #venous thromboembolism (VTE) prophylaxis
Tipo

Journal Article
Acesso ao item digital